Long-term results after treatment of very low-, low-, and high-risk thyroid cancers in a combined setting of thyroidectomy and radio ablation therapy in euthyroidism

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Emmanouilidis, Nikos ^a   Schrem, Harald ^a   Winkler, Michael ^a   Klempnauer, Jürgen ^a   Scheumann, Georg F W ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; LEVOTHYROXINE; RECOMBINANT THYROTROPIN; THYROGLOBULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ECHOGRAPHY; EUTHYROIDISM; FEMALE; FOLLOW UP; HUMAN; HYPOTHYROIDISM; JOB PERFORMANCE; MALE; MEDICAL LEAVE; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; THYROGLOBULIN BLOOD LEVEL; THYROIDECTOMY;

EID: 84880860027     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/769473     Document Type: Article

References (21)

1. Mazzaferri E. L., An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 1999 9 5 421 427 2-s2.0-0033058004 (Pubitemid 29244917)
2. Schlumberger M. J., Papillary and follicular thyroid carcinoma. The New England Journal of Medicine 1998 338 5 297 306 2-s2.0-0032576677 10.1056/NEJM199801293380506 (Pubitemid 28065257)
3. DeGroot L. J., Kaplan E. L., McCormick M., Straus F. H., Natural history, treatment, and course of papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 1990 71 2 414 424 2-s2.0-0025063417
4. Sweeney D. C., Johnston G. S., Radioiodine therapy for thyroid cancer. Endocrinology and Metabolism Clinics of North America 1995 24 4 803 839 2-s2.0-0028867031
5. Dow K. H., Ferrell B. R., Anello C., Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid 1997 7 4 613 619 2-s2.0-0030820477 (Pubitemid 27371801)
6. Luster M., Felbinger R., Dietlein M., Reiners C., Thyroid hormone withdrawal in patients with differentiated thyroid carcinoma: a one hundred thirty-patient pilot survey on consequences of hypothyroidism and a pharmacoeconomic comparison to recombinant thyrotropin administration. Thyroid 2005 15 10 1147 1155 2-s2.0-27944469859 10.1089/thy.2005.15.1147 (Pubitemid 41720721)
7. Davids T., Witterick I. J., Eski S., Walfish P. G., Freeman J. L., Three-week thyroxine withdrawal: a thyroid-specific quality of life study. Laryngoscope 2006 116 2 250 253 2-s2.0-33645776758 10.1097/01.mlg.0000192172. 61889.43 (Pubitemid 44383933)
8. Borget I., Corone C., Nocaudie M., Allyn M., Iacobelli S., Schlumberger M., De Pouvourville G., Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal. European Journal of Endocrinology 2007 156 5 531 538 2-s2.0-34248998448 10.1530/EJE-06-0724 (Pubitemid 46796519)
9. Borget I., Remy H., Chevalier J., Ricard M., Allyn M., Schlumberger M., De Pouvourville G., Length and cost of hospital stay of radioiodine ablation in thyroid cancer patients: comparison between preparation with thyroid hormone withdrawal and thyrogen. European Journal of Nuclear Medicine and Molecular Imaging 2008 35 8 1457 1463 2-s2.0-48149093877 10.1007/s00259-008-0754-9
10. Kohlfuerst S., Igerc I., Lind P., Recombinant human thyrotropin is helpful in the follow-up and 131I therapy of patients with thyroid cancer: a report of the results and benefits using recombinant human thyrotropin in clinical routine. Thyroid 2005 15 4 371 376 2-s2.0-18744363345 10.1089/thy.2005.15.371 (Pubitemid 40677411)
11. Meier C. A., Braverman L. E., Ebner S. A., Veronikis I., Daniels G. H., Ross D. S., Deraska D. J., Davies T. F., Valentine M., Degroot L. J., Curran P., Mcellin K., Reynolds J., Robbins J., Weintraub B. D., Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study). Journal of Clinical Endocrinology and Metabolism 1994 78 1 188 196 2-s2.0-0028032092 10.1210/jc.78.1.188 (Pubitemid 24026771)
12. Ladenson P. W., Braverman L. E., Mazzaferri E. L., Brucker-Davis F., Cooper D. S., Garber J. R., Wondisford F. E., Davies T. F., Degroot L. J., Daniels G. H., Ross D. S., Weintraub B. D., Hay I. D., Levis S., Reynolds J. C., Robbins J., Becker D. V., Cavalieri R. R., Maxon H. R., McEllin K., Moscicki R., Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. The New England Journal of Medicine 1997 337 13 888 896 2-s2.0-0030886175 10.1056/NEJM199709253371304 (Pubitemid 27408571)
13. Haugen B. R., Pacini F., Reiners C., Schlumberger M., Ladenson P. W., Sherman S. I., Cooper D. S., Graham K. E., Braverman L. E., Skarulis M. C., Davies T. F., Degroot L. J., Mazzaferri E. L., Daniels G. H., Ross D. S., Luster M., Samuels M. H., Becker D. V., Maxon H. R. III, Cavalieri R. R., Spencer C. A., McEllin K., Weintraub B. D., Ridgway E. C., A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. Journal of Clinical Endocrinology and Metabolism 1999 84 11 3877 3885 2-s2.0-0033341953 (Pubitemid 30644169)
14. Singer P. A., Cooper D. S., Daniels G. H., Ladenson P. W., Greenspan F. S., Levy E. G., Braverman L. E., Clark O. H., McDougall I. R., Ain K. V., Dorfman S. G., Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Archives of Internal Medicine 1996 156 19 2165 2172 2-s2.0-16044368318 10.1001/archinte.156. 19.2165 (Pubitemid 26361908)
15. Solomon B. L., Wartofsky L., Burman K. D., Current trends in the management of well differentiated papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 1996 81 1 333 339 2-s2.0-0030060628 10.1210/jc.81.1.333 (Pubitemid 26035042)
16. Mernagh P., Campbell S., Dietlein M., Luster M., Mazzaferri E., Weston A. R., Cost-effectiveness of using recombinant human TSH prior to radioiodine ablation for thyroid cancer, compared with treating patients in a hypothyroid state: the German perspective. European Journal of Endocrinology 2006 155 3 405 414 2-s2.0-33749057699 10.1530/eje.1.02223 (Pubitemid 44463946)
17. Schroeder P. R., Haugen B. R., Pacini F., Reiners C., Schlumberger M., Sherman S. I., Cooper D. S., Schuff K. G., Braverman L. E., Skarulis M. C., Davies T. F., Mazzaferri E. L., Daniels G. H., Ross D. S., Luster M., Samuels M. H., Weintraub B. D., Ridgway E. C., Ladenson P. W., A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal. Journal of Clinical Endocrinology and Metabolism 2006 91 3 878 884 2-s2.0-33644824080 10.1210/jc.2005-2064 (Pubitemid 43357753)
18. Biondo-Simões M. D. L. P., Ioshii S. O., Borsato K. S., Zimmermann E., The healing process influenced by hypothyroidism and by elderly. Study of abdominal wall healing in rats. Acta Cirúrgica Brasileira 2005 20 supplement 1 211 219 2-s2.0-38449100644
19. Natori J., Shimizu K., Nagahama M., Tanaka S., The influence of hypothyroidism on wound healing. An experimental study. Nippon Ika Daigaku Zasshi 1999 66 3 176 180 2-s2.0-0033146397
20. Safer J. D., Crawford T. M., Holick M. F., A role for thyroid hormone in wound healing through keratin gene expression. Endocrinology 2004 145 5 2357 2361 2-s2.0-2042470094 10.1210/en.2003-1696 (Pubitemid 38535065)
21. Emmanouilidis N., Müller J. A., Jäger M. D., Kaaden S., Helfritz F. A., Güner Z., Kespohl H., Knitsch W., Knapp W. H., Klempnauer J., Scheumann G. F. W., Surgery and radioablation therapy combined: introducing a 1-week-condensed procedure bonding total thyroidectomy and radioablation therapy with recombinant human TSH. European Journal of Endocrinology 2009 161 5 763 769 2-s2.0-70449732263 10.1530/EJE-08-0641